RXRX · Recursion Pharmaceuticals, Inc. · Documents
$3.64
-0.02 (-0.55%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.96B
Shares
535.34M
Volume · Oct 21
19.36M
Avg daily vol (3M)
21.71M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEF 14A | — | 2023-04-28 | — | |
| 8-K | — | 2023-03-10 | — | |
| 8-K | — | 2023-02-27 | — | |
| 10-K | — | 2023-02-27 | 2022-12-31 | |
| 8-K | — | 2023-01-25 | — | |
| 8-K | — | 2023-01-13 | — | |
| 8-K | — | 2023-01-10 | — | |
| 8-K | — | 2022-11-08 | — | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-10-25 | 2022-10-24 | |
| 8-K | — | 2022-09-13 | — | |
| 10-Q | — | 2022-08-09 | 2022-06-30 | |
| 8-K | — | 2022-08-09 | — | |
| 8-K | — | 2022-06-21 | 2022-06-20 | |
| 8-K | — | 2022-06-16 | 2022-06-14 | |
| 8-K | — | 2022-06-09 | 2022-06-07 | |
| 8-K | — | 2022-05-10 | — | |
| S-3ASR | — | 2022-05-10 | — | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| DEF 14A | — | 2022-04-28 | 2022-06-14 | |
| DEFA14A | — | 2022-04-28 | — | |
| 8-K | — | 2022-04-11 | — | |
| 8-K | — | 2022-03-23 | — | |
| 10-K | — | 2022-03-23 | 2021-12-31 | |
| 8-K | — | 2022-03-18 | — | |
| 8-K | — | 2022-03-03 | — | |
| 8-K | — | 2022-01-10 | — | |
| 8-K | — | 2021-12-07 | 2021-12-05 | |
| 8-K | — | 2021-12-06 | 2021-12-02 | |
| 8-K | — | 2021-11-10 | — | |
| 10-Q | — | 2021-11-10 | 2021-09-30 | |
| 8-K | — | 2021-10-07 | — | |
| 8-K | — | 2021-09-09 | — | |
| 10-Q | — | 2021-08-13 | 2021-06-30 | |
| 8-K | — | 2021-08-13 | — | |
| 8-K | — | 2021-07-13 | — | |
| 10-Q | — | 2021-05-12 | 2021-03-31 | |
| 8-K | — | 2021-05-12 | — | |
| 8-K | — | 2021-04-21 | 2021-04-20 | |
| S-1 | — | 2021-03-22 | — |
Showing 101–140 of 140 filings
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
41 filings
41 filers
Visit website
Investor relations